ReviewAnnals of cardiothoracic surgery2022
Complications and their management in robotic mitral valve surgery from the surgical assistant's perspective.
Review in Annals of cardiothoracic surgery, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed, 4 citations in OpenAlex.
- Transpericardial Left Atrial/Left Ventricular Vent Placement During Robotic Mitral Surgery.Interdisciplinary cardiovascular and thoracic surgery · 2026Article
- Anatomy-based individualised trocar placement in robotic pancreatic surgery: challenging the universal approach.Journal of robotic surgery · 2026Article
- Long-term mortality following robotic mitral valve repair.JTCVS structural and endovascular · 2026Article
- Robotic degenerative mitral valve repair: an evolution.Annals of cardiothoracic surgery · 2026Review
- Comparison of Endoaortic Balloon Occlusion and Transthoracic Aortic Clamp for Minimally Invasive Cardiac Surgery: Systematic Review and Meta-analysis.The International journal of angiology : official publication of the International College of Angiology, Inc · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Robotic mitral valve (MV) repair is an alternative approach to traditional MV repair via median sternotomy. There is a rich history of innovation embedded within robotic MV surgery. Since the inaugural robotic MV repair performed in May 1998 by Carpentier, progressive techniques and expanding indications have given surgeons the opportunity to offer an increasing number of their patients access to robotic MV surgery. This, coupled with less cynicism surrounding robotic and minimally invasive surgery, has stimulated robotic cardiac surgery program development and the number of robotic MV procedures performed annually. Utilizing the robotic technology in MV surgery is far from the standard of care and must be approached modestly by only well trained and experienced cardiothoracic surgeons and teams. Advanced surgical techniques provide numerous opportunities for complications and adverse outcomes. It is essential for the entire robotic cardiac surgery team to be aware of the additional risks during each step of the procedure. The fundamental principle of robotic MV repair is to avoid complications with anticipation. No surgery is without risk, and unfortunately, some of those risks are unavoidable. If a complication does occur, it is essential the surgeon and robotic team understand their roles and how to triage the event. This keynote lecture will outline each phase of the robotic MV repair surgery before, during and after the patient cart is docked to the patient. Within each phase we will identify potential complications and their management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.